WANBURY
Back to Income Statement
|
WANBURY Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹-10 Cr | ₹81 Cr | ₹-13 Cr | ₹64 Cr | ₹-25 Cr |
What is the latest Consolidated Net Profit of WANBURY ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹-10 Cr |
Mar2023 | ₹81 Cr |
Mar2022 | ₹-13 Cr |
Mar2021 | ₹64 Cr |
Mar2020 | ₹-25 Cr |
How is Consolidated Net Profit of WANBURY Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹-10 Cr | Negative | |
Mar2023 | ₹81 Cr | Positive | |
Mar2022 | ₹-13 Cr | Negative | |
Mar2021 | ₹64 Cr | Positive | |
Mar2020 | ₹-25 Cr | - |
Compare Consolidated Net Profit of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹856.4 Cr | -4.2% | 3.9% | 12.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
CIPLA | ₹127,126.0 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,700.0 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -4.2% |
3.9% |
12.5% |
SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses